European Association of Urology

SHERPA: Unknown

People

  1. Carlsson
    Carlsson
  2. Eastham
    Eastham
  3. Gonen
    Gonen
  4. Motzer
    Motzer

Groups

  1. Epidemiology and Biostatistics (2)
  2. Surgery (2)
  3. Urology (2)
  4. Biostatistics Service (1)
  5. Center for Pancreatic Cancer Research (1)
  6. Department of Medicine (1)
  7. Genitourinary Oncology Service (1)
  8. Health Outcomes Research Group (1)
  9. Population Sciences Research Program (1)
  10. Solid Tumor Oncology Division (1)
Search Within
  1. "2012"
Formats
  1. Meeting Abstract (4)
Groups
  1. Epidemiology and Biostatistics (2)
  2. Surgery (2)
  3. Urology (2)
  4. Biostatistics Service (1)
  5. Center for Pancreatic Cancer Research (1)
  6. Department of Medicine (1)

More Groups

People
  1. James Eastham (1)
  2. Mithat Gonen (1)
  3. Robert Motzer (1)
  4. Sigrid Carlsson (1)
Years
  1. 2012 (4)
Publications
  1. European Urology, Supplements (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate-specific antigen kinetics in patients with bone metastases from castration-resistant prostate cancer receiving zoledronic acid therapy
    Meeting Abstract

    Saad, F.; PeĢrez, J.; Segal, S.; Eastham, J.
    European Urology, Supplements (2012)

    Fulltext@MSK | Save
  • Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment
    Meeting Abstract

    Rink, M.; Ehdaie, B.; Cha, E. K.; Hansen, J.; Svatek, R.; Chromecki, T. F.; Fajkovic, H.; Novara, G.; Daneshmand, S.; Fradet, Y.; more...
    European Urology, Supplements (2012)

    Fulltext@MSK | Save
  • Updated results of the phase 3 AXIS trial: Axitinib vs sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Escudier, B.; Rini, B. I.; Hutson, T. E.; Gore, M.; Oudard, S.; Tarazi, J.; Rosbrook, B.; Williams, J. A.; Kim, S.; Motzer, R. J.
    European Urology, Supplements (2012)

    Fulltext@MSK | Save
  • Outcomes after various primary treatment for non-metastasised prostate cancer. A report from the European randomized screening trial for prostate cancer (ERSPC)
    Meeting Abstract

    Carlsson, S.; Moss, S.; Auvinen, A.; Denis, L. J.; Kwiatkowski, M. K.; Nelen, V.; Recker, F.; Roobol, M. J.; Schroder, F. H.; Tammela, T. L. J.; more...
    European Urology, Supplements (2012)

    Fulltext@MSK | Save

    • European Association of Urology – authorized name for: